Assessment For Retreatment with TACE (ART) Score
Assessment for Retreatment with TACE (ART) Score is an assessment tool used to determine the suitability of retreatment with trans-arterial chemoembolization (TACE) in patients with hepatocellular carcinoma (HCC).
Patient with a score of 2.5 or more prior to Re TACE may not benefit from the procedure.
ART score was developed using the radiologic EASL-response criteria (PR = greater than 50% tumor reduction) rather than mRECIST criteria (PR = greater than 30% tumor reduction). ¹
| Parameters | Points |
|---|---|
| Absence of radiological response | 1 Point |
| AST (aspartate aminotransferase) increase > 25% | 4 Points |
| Child-Pugh Score increase by: 1 Point 2 Points | 1.5 Points 3 Points |
| Total | 0-1.5 = Excellent Prognosis after Re TACE ≥ 2.5 = Dismal Prognosis after Re TACE |
- Sieghart W, Hucke F, Pinter M, Graziadei I, Vogel W, Müller C, Heinzl H, Trauner M, Peck‐Radosavljevic M. The ART of decision making: retreatment with transarterial chemoembolization in patients with hepatocellular carcinoma. Hepatology. 2013 Jun;57(6):2261-73.
- Karademir S. Staging of hepatocellular carcinoma. Hepatoma Res. 2018;4:58.
- Kinoshita, Akiyoshi et al. “Staging systems for hepatocellular carcinoma: Current status and future perspectives.” World journal of hepatology vol. 7,3 (2015): 406-24. doi:10.4254/wjh.v7.i3.406